The University of Akron’s new Early Assurance Pathway to Nurse Anesthesia Program will ensure students meet critical program ...
Shares of COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) have received a consensus recommendation of “Buy” from the six ...
JAMESTOWN — Jamestown Regional Medical Center’s application to the American Nurses Credentialing Center’s (ANCC) Pathway to ...
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has announced results from a clinical study recently published in The Neurohospitalist highlighting the ...
Medtronic announced that new findings from the company-sponsored DiVERT Stroke clinical study showed women spent less time in t ...
The BornToGetThere project has been set to advance early detection, surveillance, and intervention for infants at high risk ...
The joint initiative between Royal Philips and the World Bank and MOH delivers advanced image-guided therapy systems ...
The University of Akron (Ohio) has launched an "early assurance" pathway for students interested in nurse anesthesia careers, according to a Feb. 10 report from Cleveland.com. The new program offers ...
A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...
OT asked the experts what delegates can expect to hear in clinical imaging, from skills development to applications of the latest techniques, at 100% Optical 2025 ...
Novartis has agreed to acquire Anthos Therapeutics, Inc., a Boston-based, privately held, clinical-stage biopharmaceutical ...
About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...